Acetylcholine Receptor-Induced Experimental Myasthenia Gravis: What Have We Learned from Animal Models After Three Decades?

Ex Vivo Generated Regulatory T Cells Modulate Experimental Autoimmune Myasthenia Gravis

(2014) R. Aricha et al.   JOURNAL OF IMMUNOLOGY

Pixantrone (BBR2778) Reduces the Severity of Experimental Autoimmune Myasthenia Gravis in Lewis Rats

(2014) F. Ubiali et al.   JOURNAL OF IMMUNOLOGY

Proteasome Inhibition with Bortezomib Depletes Plasma Cells and Autoantibodies in Experimental Autoimmune Myasthenia Gravis

(2011) A. M. Gomez et al.   JOURNAL OF IMMUNOLOGY

Current and emerging therapies for the treatment of myasthenia gravis

(2011) Renato Mantegazza   Neuropsychiatric Disease and Treatment

Antibody effector mechanisms in myasthenia gravis—Pathogenesis at the neuromuscular junction

(2010) Alejandro M. Gomez et al.   AUTOIMMUNITY

Immunosuppressive therapies in myasthenia gravis

(2010) Donald B. Sanders et al.   AUTOIMMUNITY

Expansion of regulatory T cells via IL-2/anti-IL-2 mAb complexes suppresses experimental myasthenia

(2010) Ruolan Liu et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

The susceptibility of Aire−/− mice to experimental myasthenia gravis involves alterations in regulatory T cells

(2010) Revital Aricha et al.   JOURNAL OF AUTOIMMUNITY

Naturally Occurring CD4+CD25+ Regulatory T Cells Prevent but Do Not Improve Experimental Myasthenia Gravis

(2010) V. Nessi et al.   JOURNAL OF IMMUNOLOGY

Undiminished regulatory T cells in the thymus of patients with myasthenia gravis

(2010) N. Matsui et al.   NEUROLOGY

Novel complement inhibitor limits severity of experimentally myasthenia gravis

(2009) Jindrich Soltys et al.   ANNALS OF NEUROLOGY

BM stromal cells ameliorate experimental autoimmune myasthenia gravis by altering the balance of Th cells through the secretion of IDO

(2009) Qing-fei Kong et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

T-bet deficiency decreases susceptibility to experimental myasthenia gravis

(2009) Ruolan Liu et al.   EXPERIMENTAL NEUROLOGY

Disequilibrium of T helper type 1, 2 and 17 cells and regulatory T cells during the development of experimental autoimmune myasthenia gravis

(2009) Lili Mu et al.   IMMUNOLOGY

Suppression of ongoing experimental autoimmune myasthenia gravis by transfer of RelB-silenced bone marrow dentritic cells is associated with a change from a T helper Th17/Th1 to a Th2 and FoxP3+ regulatory T-cell profile

(2009) Huan Yang et al.   INFLAMMATION RESEARCH

Administration of bone marrow stromal cells ameliorates experimental autoimmune myasthenia gravis by altering the balance of Th1/Th2/Th17/Treg cell subsets through the secretion of TGF-β

(2009) Qing-fei Kong et al.   JOURNAL OF NEUROIMMUNOLOGY

Main Immunogenic Region Structure Promotes Binding of Conformation-Dependent Myasthenia Gravis Autoantibodies, Nicotinic Acetylcholine Receptor Conformation Maturation, and Agonist Sensitivity

(2009) J. Luo et al.   JOURNAL OF NEUROSCIENCE

Autoimmune myasthenia gravis: emerging clinical and biological heterogeneity

(2009) Matthew N Meriggioli et al.   LANCET NEUROLOGY

'Seronegative' myasthenia gravis is no longer seronegative

(2008) J. Lindstrom   BRAIN

C5a is not involved in experimental autoimmune myasthenia gravis pathogenesis

(2008) H QI et al.   JOURNAL OF NEUROIMMUNOLOGY